All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F22%3A43921058" target="_blank" >RIV/62156489:43210/22:43921058 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1186/s12943-022-01503-1" target="_blank" >https://doi.org/10.1186/s12943-022-01503-1</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12943-022-01503-1" target="_blank" >10.1186/s12943-022-01503-1</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer

  • Original language description

    Head and neck cancer is the sixth most common cancer across the globe. This is generally associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises through human papillomavirus (HPV) infection, thus classifying head and neck squamous cell carcinoma (HNSCC) into HPV-positive and HPV-negative HNSCCs. Aberrant, mesenchymal-epithelial transition factor (c-MET) signal transduction favors HNSCC progression by stimulating proliferation, motility, invasiveness, morphogenesis, and angiogenesis. c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas. c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLCγ), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways. c-MET also establishes a crosstalk pathway with epidermal growth factor receptor (EGFR) and contributes towards chemoresistance in HNSCC. In recent years, the signaling communications of c-MET/HGF in metabolic dysregulation, tumor-microenvironment and immune modulation in HNSCC have emerged. Several clinical trials have been established against c-MET/ hepatocyte growth factor (HGF) signaling network to bring up targeted and effective therapeutic strategies against HNSCC. In this review, we discuss the molecular mechanism(s) and current understanding of c-MET/HGF signaling and its effect on HNSCC.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10601 - Cell biology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Molecular Cancer

  • ISSN

    1476-4598

  • e-ISSN

    1476-4598

  • Volume of the periodical

    21

  • Issue of the periodical within the volume

    26 January

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    16

  • Pages from-to

    31

  • UT code for WoS article

    000749248800002

  • EID of the result in the Scopus database

    2-s2.0-85123586457